Disease activity impacts disability progression in primary progressive multiple sclerosis

被引:16
|
作者
Marrodan, M. [1 ]
Bensi, C. [1 ]
Pappolla, A. [2 ]
Rojas, J. I. [2 ,3 ]
Gaitan, M. I. [1 ]
Ysrraelit, M. C. [1 ]
Negrotto, L. [1 ]
Fiol, M. P. [1 ]
Patrucco, L. [2 ,3 ]
Cristiano, E. [3 ]
Farez, M. F. [1 ,4 ]
Correale, J. [1 ]
机构
[1] Fleni, Dept Neurol, Montaneses 2325, RA-1428 Buenos Aires, DF, Argentina
[2] Hosp Italiano Buenos Aires, Dept Neurol, Buenos Aires, DF, Argentina
[3] Ctr Esclerosis Multiple Buenos Aires, Buenos Aires, DF, Argentina
[4] Fleni, Ctr Biostat Epidemiol & Publ Hlth CEBES, Buenos Aires, DF, Argentina
关键词
Primary progressive multiple sclerosis; PPMS; Multiple Sclerosis; Disability worsening; Disability progression; NATURAL-HISTORY; PROGNOSTIC-FACTORS; MRI; MS; PREDICTORS;
D O I
10.1016/j.msard.2019.101892
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Although solid information on the natural history of primary progressive multiple sclerosis (PPMS) is available, evidence regarding impact of disease activity on PPMS progression remains controversial. Objective: To describe the clinical characteristics, presence or absence of MRI activity, and natural history of a PPMS cohort from two referral centers in Argentina and assess whether clinical and/or radiological disease activity correlated with disability worsening. Methods: Retrospective study conducted at two MS clinics in Buenos Aires, Argentina, through comparative analysis of patients with and without evidence of disease activity. Results: Clinical and/or radiologic activity was presented in 56 (31%) of 178 patients. When stratified by age at onset, we found that for every 10 years of increase in age at onset, risk of reaching EDSS scores of 4 and 6 increased by 26% and 31%, respectively (EDSS 4: HR 1.26, CI 95%: 1.06-1.50; EDSS 6: HR 1.31, CI 95%: 1.06-1.62). Patients who presented clinical exacerbations reached EDSS scores of 6, 7 and 8 faster than those without associated exacerbations (p = 0.009, p = 0.016 and p = 0.001, respectively). Likewise, patients who presented gadolinium-enhancing lesions during the course of disease reached EDSS scores of 7 earlier (p = 0.002). Conclusion: Older age at onset and presence of clinical and/or radiological disease activity correlated with accelerated disability progression in this cohort of PPMS patients.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Mechanisms of disability progression in primary progressive multiple sclerosis: are they different from secondary progressive multiple sclerosis?
    Rudick, R
    MULTIPLE SCLEROSIS, 2003, 9 (02): : 210 - 212
  • [2] Disease activity has a significant impact in progression of primary progressive multiple sclerosis
    Marrodan, M.
    Bensi, C.
    Pappolla, A.
    Rojas, J. I.
    Patrucco, L.
    Farez, M. F.
    Cristiano, E.
    Correale, J.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 382 - 382
  • [3] Prediction of Disease Progression in Primary Progressive Multiple Sclerosis
    Patrucco, Liliana
    Ignacio Rojas, Juan
    Cristiano, Edgardo
    NEUROLOGY, 2010, 74 (09) : A69 - A69
  • [4] Association of Complement Factors With Disability Progression in Primary Progressive Multiple Sclerosis
    Lunemann, Jan D.
    Hegen, Harald
    Villar, Luisa Maria
    Rejdak, Konrad
    Sao-Aviles, Augusto
    Carbonell-Mirabent, Pere
    Sastre-Garriga, Jaume
    Mongay-Ochoa, Neus
    Berek, Klaus
    Martinez-Yelamos, Sergio
    Perez-Miralles, Francisco
    Abdelhak, Ahmed
    Bachhuber, Franziska
    Tumani, Hayrettin
    Lycke, Jan N.
    Rosenstein, Igal
    Alvarez-Lafuente, Roberto
    Castillo-Trivino, Tamara
    Otaegui, David
    Llufriu, Sara
    Blanco, Yolanda
    Sanchez Lopez, Antonio J.
    Garcia Merino, Juan Antonio
    Fissolo, Nicolas
    Gutierrez, Lucia
    Villacieros-Alvarez, Javier
    Monreal, Enric
    Valls-Carbo, Adrian
    Wiendl, Heinz
    Montalban, Xavier
    Comabella, Manuel
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2024, 11 (04):
  • [5] Disease activity in Primary Progressive Multiple Sclerosis
    Vural, Atay
    Kurne, Asli T.
    Sayat, Guliz
    Derle, Eda
    Karabudak, Rana N.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 30 - 30
  • [6] Anti-inflammatory disease modifying treatment and disability progression in primary progressive multiple sclerosis
    Lorscheider, J.
    Kuhle, J.
    Izquierdo, G.
    Lugaresi, A.
    Havrdova, E.
    Horakova, D.
    Hupperts, R.
    Duquette, P.
    Girard, M.
    Prat, A.
    Grand'Maison, F.
    Grammond, P.
    Sola, P.
    Ferraro, D.
    Trojano, M.
    Ramo-Tello, C.
    Lechner-Scott, J.
    Pucci, E.
    Slee, M.
    Van Pesch, V.
    Van der Walt, A.
    Butzkueven, H.
    Kappos, L.
    Kalincik, T.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 398 - 399
  • [7] Disease activity in primary progressive multiple sclerosis
    Vural, A.
    Karabudak, R. N.
    Sayat, G.
    Derle, E.
    Kurne, A. T.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 721 - 721
  • [8] Chronic lesion activity and disability progression in secondary progressive multiple sclerosis
    Beynon, Vanessa
    George, Ilena C.
    Elliott, Colm
    Arnold, Douglas L.
    Ke, Jun
    Chen, Huaihou
    Zhu, Li
    Ke, Chunlei
    Giovannoni, Gavin
    Scaramozza, Matthew
    Campbell, Nolan
    Bradley, Daniel P.
    Franchimont, Nathalie
    Gafson, Arie
    Belachew, Shibeshih
    BMJ NEUROLOGY OPEN, 2022, 4 (01)
  • [9] Disability accumulation in primary progressive multiple sclerosis
    Koch, M.
    Kingwell, E.
    Rieckmann, P.
    Tremlett, H.
    MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (09) : S40 - S40
  • [10] Disability Accrual in Primary Progressive & Secondary Progressive Multiple Sclerosis
    Harding-Forrester, Sam
    Roos, Izanne
    Sharmin, Sifat
    Diouf, Ibrahima
    Malpas, Charles
    Nguyen, Ai-Lan
    Moradi, Nahid
    Horakova, Dana
    Havrdova, Eva Kubala
    Patti, Francesco
    Ayuso, Guillermo Izquierdo
    Madueno, Sara Eichau
    Prat, Alexandre
    Girard, Marc
    Duquette, Pierre
    Onofrj, Marco
    Lugaresi, Alessandra
    Grand'Maison, Francois
    Weinstock-Guttman, Bianca
    Amato, Maria Pia
    Grammond, Pierre
    Gerlach, Oliver
    Ozakbas, Serkan
    Sola, Patrizia
    Ferraro, Diana
    Butzkueven, Helmut
    Lechner-Scott, Jeannette
    Boz, Cavit
    Alroughani, Raed
    Van Pesch, Vincent
    Cartechini, Elisabetta
    Terzi, Murat
    Maimone, Davide
    Ramo-Tello, Cristina
    Spitaleri, Daniele Litterio A.
    Kappos, Ludwig
    Yamout, Bassem
    Sa, Maria Jose
    Slee, Mark
    Morgado, Yolanda Blanco
    Bergamaschi, Roberto
    Butler, Ernest
    Iuliano, Gerardo
    Granella, Franco
    Sidhom, Youssef
    Gouider, Riadh
    Ampapa, Radek
    Van Wijmeersch, Bart
    Karabudak, Rana
    Prevost, Julie
    NEUROLOGY, 2021, 96 (15)